Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sufian Ahmad

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Experimental Orthopaedics|November 3, 2025
Rising star editorial: Periacetabular osteotomy-Reliable outcome and expanding indicationsLorenz Pichler, Sufian Ahmad
Current Drug Targets|February 17, 2025
Proteases and Osteoporosis: A Comprehensive Review of Their Role in Bone HealthSyed Sufian Ahmad, Faraha Ahmed, Sayeed Ahmad, et al.
Iranian Journal of Basic Medical Sciences|February 19, 2025
Targeting dipeptidyl peptidase-8/9 to combat inflammation-induced osteoclastogenesis in RAW264.7 macrophages and analysis of anti-osteoclastogenesis potential of chrysinSyed Sufian Ahmad, Faraha Ahmed, Sayeed Ahmad, et al.
Journal of Orthopaedics|March 23, 2023
Fibula pro tibia and cancellous allograft vitalised with autologous bone for non-union of the distal tibia diaphysis: Surgical techniqueGregor M Giebel, Ulrich Stöckle, Atesch Ateschrang, et al.
The Journal of Pharmacy and Pharmacology|September 4, 2024
Unravelling the role of dipeptidyl peptidases-8/9 (DPP-8/9) in inflammatory osteoporosis: a comprehensive study investigating chrysin as a potential anti-osteoporotic agentSyed Sufian Ahmad, Faraha Ahmed, Mohd Mumtaz Alam, et al.
Thrombosis and Haemostasis|October 8, 2011
False normal von Willebrand factor activity by monoclonal antibody-based ELISA in a patient with type 2A(IID) von Willebrand diseaseSufian Ahmad, Beverly Ptashkin, Cara DiGiovanni, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 27, 2021
[What constitutes a good osteosynthesis?]Sven Märdian, Serafeim Tsitsilonis, Sufian Ahmad, et al.
Archiv Der Pharmazie|October 17, 2023
Design, synthesis, biological evaluation, and in silico studies of quinoxaline derivatives as potent p38α MAPK inhibitorsAnjali, Payal Kamboj, Ozair Alam, et al.
3 Biotech|June 1, 2026
Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signalingTufail Ahmad, Syed Sufian Ahmad, Faraha Ahmed, et al.
Emergency Medicine International|September 23, 2016
Mandibular Fractures Admitted to the Emergency Department: Data Analysis from a Swiss Level One Trauma CentreKemal Yildirgan, Edris Zahir, Siamak Sharafi, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Experimental Orthopaedics|November 3, 2025
Rising star editorial: Periacetabular osteotomy-Reliable outcome and expanding indicationsLorenz Pichler, Sufian Ahmad
Current Drug Targets|February 17, 2025
Proteases and Osteoporosis: A Comprehensive Review of Their Role in Bone HealthSyed Sufian Ahmad, Faraha Ahmed, Sayeed Ahmad, et al.
Iranian Journal of Basic Medical Sciences|February 19, 2025
Targeting dipeptidyl peptidase-8/9 to combat inflammation-induced osteoclastogenesis in RAW264.7 macrophages and analysis of anti-osteoclastogenesis potential of chrysinSyed Sufian Ahmad, Faraha Ahmed, Sayeed Ahmad, et al.
Journal of Orthopaedics|March 23, 2023
Fibula pro tibia and cancellous allograft vitalised with autologous bone for non-union of the distal tibia diaphysis: Surgical techniqueGregor M Giebel, Ulrich Stöckle, Atesch Ateschrang, et al.
The Journal of Pharmacy and Pharmacology|September 4, 2024
Unravelling the role of dipeptidyl peptidases-8/9 (DPP-8/9) in inflammatory osteoporosis: a comprehensive study investigating chrysin as a potential anti-osteoporotic agentSyed Sufian Ahmad, Faraha Ahmed, Mohd Mumtaz Alam, et al.
Thrombosis and Haemostasis|October 8, 2011
False normal von Willebrand factor activity by monoclonal antibody-based ELISA in a patient with type 2A(IID) von Willebrand diseaseSufian Ahmad, Beverly Ptashkin, Cara DiGiovanni, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 27, 2021
[What constitutes a good osteosynthesis?]Sven Märdian, Serafeim Tsitsilonis, Sufian Ahmad, et al.
Archiv Der Pharmazie|October 17, 2023
Design, synthesis, biological evaluation, and in silico studies of quinoxaline derivatives as potent p38α MAPK inhibitorsAnjali, Payal Kamboj, Ozair Alam, et al.
3 Biotech|June 1, 2026
Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signalingTufail Ahmad, Syed Sufian Ahmad, Faraha Ahmed, et al.
Emergency Medicine International|September 23, 2016
Mandibular Fractures Admitted to the Emergency Department: Data Analysis from a Swiss Level One Trauma CentreKemal Yildirgan, Edris Zahir, Siamak Sharafi, et al.
Pageof 2